CRISPLD1 and gastric cancer: Consequently, treatment with a specific AKT activator (SC79) eliminated the inhibitory effect of CRISPLD1 knockdown on GC cell migration and invasion, supporting the concept that CRISPLD1 mediates GC cell migration and invasion through the PI3K-AKT signaling pathway.